Increasing Complexity in Drug Safety Management

The landscape of drug safety is evolving, with a growing emphasis on the critical role pharmacists play in ensuring medication safety. During a panel discussion held at Berlin's Charité hospital, experts highlighted the importance of pharmacists in managing potential quality issues, side effects, and medication errors. This event marked the 50th anniversary of the Drug Commission of the German Pharmaceutical Association (AMK), underscoring the need for a robust pharmacy profession to navigate the complexities of modern medication therapy.

Professor Werner Knöss, Vice President of the Federal Institute for Drugs and Medical Devices (BfArM), praised the quality of reports submitted by pharmacies to the AMK, emphasizing the commitment of individual pharmacies to patient safety. As the pharmaceutical market continues to evolve rapidly, it is crucial for all stakeholders to contribute their expertise for the benefit of patients.

Modern medications increasingly require sophisticated administration methods, such as subcutaneous injections, which present higher risks for errors and require comprehensive patient education. AMK Chairman Professor Martin Schulz noted that while patients may believe they are well-informed, studies consistently reveal that many misuse devices like inhalers or misunderstand their medication plans.

Armin Hoffmann, President of the Federal Chamber of Pharmacists (BAK), concurred on the growing complexity of medication therapy. He stressed the necessity of pharmacists' knowledge not just in pharmacology, drug interactions, and pharmacokinetics but also in technology and communication. He pointed out the unique position of pharmacists in directly interacting with patients and understanding their real experiences with medications.

Hoffmann also emphasized the importance of pharmacists leading the development and maintenance of medication plans, where all prescriptions, over-the-counter purchases, and actual usage converge. This comprehensive approach is vital for effective medication management.

Georg Kippels, Parliamentary State Secretary in the Federal Ministry of Health, supported the increased utilization of medication plans, particularly in the context of the electronic patient file (ePA). He expressed hope that such systems will help reduce unnecessary examinations and therapies while preventing harmful interactions, thus safeguarding both health and financial resources.